Fed-batch - upstream and downstream manufacturing
Harness our flexible upstream and downstream fed-batch manufacturing solutions designed to push your products further.
What is fed-batch manufacturing?
Fed-batch manufacturing is a well-established approach to biologics production. In fed-batch manufacturing, nutrients are gradually fed into the bioreactor, allowing for better control over cell growth and product formation.
Compared to batch culture, fed-batch manufacturing offers several advantages, including:
- Increased cell densities
- Higher product titers
- Reduced fermentation times
Process control strategies to maintain optimal growth conditions and minimize product degradation can also be performed in fed-batch manufacturing.
We can provide flexible fed-batch bioprocess manufacturing that can cover all of your upstream and downstream processing needs or support as you transfer from fed-batch to our continuous bioprocess manufacturing platform, EnzeneX™.
Why partner with Enzene for fed-batch manufacturing?
We are a global CDMO and biosimilar developer dedicated to impacting the global healthcare landscape by bringing trusted and affordable medicines to market, quickly.
Committed to innovation, we have revolutionized biologics production with our patented and validated continuous bioprocess manufacturing platform, EnzeneX™, that enables us to significantly reduce the cost of producing complex biologics and monoclonal antibodies (mAbs).
Our fully-integrated services and productive pipeline of biosimilars, along with our fed-batch manufacturing solutions, are designed to cater to your project’s every need.
Related case studies
Latest resources
Join the manufacturing revolution
Fueled by our continuous innovation and armed with EnzeneX™, our fully-integrated CDMO solutions and our biosimilars pipeline are designed to help bring your biologics innovations to life.